CIK 0001799191
- Accelerated filer
- Smaller reporting company
Starling Oncology, Inc.
Sign in to watch- Tickers
- STLN STLNW DFPH
- Exchange
- Nasdaq, OTC
- Industry
- Services-Offices & Clinics of Doctors of Medicine
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 843562323
- Phone
- +1 562-735-3226
- Business address
- 18000 STUDEBAKER RD, SUITE 800, CERRITOS, CA, 90703
- Former names
- Oncology Institute, Inc., DFP HEALTHCARE ACQUISITIONS CORP.
Securities
- STLN Common Stock Nasdaq
- STLNW Common stock Nasdaq
- DFPH Common stock OTC
- Open-market buys, last 90 days
- $176,273
- in 1 filing
- Open-market sales, last 90 days
- $13,322,043
- in 2 filings, $1.9M under 10b5-1 plans
Net −$13,145,770. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-03-21 | Hively Brad Chief Executive Officer | Grant or award · Stock Option (right to buy) | +550,563 | 550,563 | ||
| 2022-03-21 | Dalgleish Scott Chief Financial Officer | Grant or award | +32,092 | 151,008 | ||
| 2022-03-21 | Dalgleish Scott Chief Financial Officer | Grant or award · Stock Option (right to buy) | +26,062 | 26,062 | ||
| 2022-03-21 | SARIN RAVI YANG Director | Grant or award | +15,994 | 15,994 | ||
| 2022-03-21 | SARIN RAVI YANG Director | Grant or award | +7,197 | 23,191 | ||
| 2022-03-21 | Hively Brad Chief Executive Officer | Grant or award | +108,469 | 461,919 | ||
| 2022-03-21 | Hively Brad Chief Executive Officer | Grant or award · Stock Option (right to buy) | +88,090 | 88,090 | ||
| 2022-03-21 | O'Meara Maeve Director | Grant or award | +15,994 | 15,994 | ||
| 2022-03-21 | O'Meara Maeve Director | Grant or award | +3,998 | 19,992 | ||
| 2022-03-21 | Virnich Daniel President | Grant or award | +42,015 | 237,251 | ||
| 2022-03-21 | Virnich Daniel President | Grant or award · Stock Option (right to buy) | +34,121 | 34,121 | ||
| 2022-03-21 | Kaushal Mohit Director | Grant or award | +15,994 | 41,528 | ||
| 2022-03-21 | Kaushal Mohit Director | Grant or award | +4,798 | 46,326 | ||
| 2022-03-21 | Podnos Yale Chief Medical Officer | Grant or award | +2,164 | 30,562 | ||
| 2022-03-21 | Podnos Yale Chief Medical Officer | Grant or award | +12,720 | 43,282 | ||
| 2022-03-21 | Podnos Yale Chief Medical Officer | Grant or award · Stock Option (right to buy) | +1,757 | 1,757 | ||
| 2022-03-21 | Podnos Yale Chief Medical Officer | Grant or award · Stock Option (right to buy) | +10,330 | 10,330 | ||
| 2022-03-21 | Miller Matthew P Chief Operating Officer | Grant or award | +6,386 | 56,970 | ||
| 2022-03-21 | Miller Matthew P Chief Operating Officer | Grant or award | +21,641 | 78,611 | ||
| 2022-03-21 | Miller Matthew P Chief Operating Officer | Grant or award · Stock Option (right to buy) | +5,186 | 5,186 |
Page 19 of 23 · 442 trades